Vivo Bio Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve 1. To consider and approve the Audited Standalone & Consolidated Financial Results of the Company for the Fourth Quarter and Year ended March 31, 2026. 2. To consider and approve the amalgamation of M/s. Shri Shri Resorts Private Limited (Transferor Company) with and into M/s. Vivo Bio Tech Limited (Transferee Company) under Sections 230 to 232 and other relevant provisions of the Companies Act, 2013, SEBI Listing Regulations etc.
Board Meeting Intimation for Meeting Tobe Held On Friday, May 29, 2026
Filed with BSE · · 1 page · English
Release
Story so far
Earlier from Vivo Bio Tech
- Vivo Bio Tech Ltd. Press Release Apr 13 2026
- Report On Re-Lodgement Of Transfer Requests Of Physical Shares
- Vivo Bio Tech Ltd. Press Release Apr 07 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Vivo Bio Tech Ltd. Press Release Apr 06 2026
Later from Vivo Bio Tech
- Board Meeting Outcome for Outcome Of The Board Meeting
- Audited Standalone & Consolidated Financial Results For The Fourth Quarter And Year Ended March 31, 2026
- Announcement under Regulation 30 (LODR)-Change in Management
- Vivo Bio Tech Ltd. Press Release May 30 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
Follow Vivo Bio Tech into a list and get an email when it puts out news.
Follow Vivo Bio Tech